Outset Medical, Inc. (OM)
- Previous Close
15.88 - Open
15.65 - Bid 15.13 x 100
- Ask 15.39 x 100
- Day's Range
15.08 - 16.71 - 52 Week Range
5.85 - 72.60 - Volume
294,649 - Avg. Volume
125,787 - Market Cap (intraday)
271.147M - Beta (5Y Monthly) 1.90
- PE Ratio (TTM)
-- - EPS (TTM)
-36.90 - Earnings Date Aug 5, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
22.25
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
www.outsetmedical.comRecent News: OM
View More
Performance Overview: OM
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: OM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: OM
View MoreValuation Measures
Market Cap
271.15M
Enterprise Value
314.32M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.47
Price/Book (mrq)
10.11
Enterprise Value/Revenue
2.76
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-112.57%
Return on Assets (ttm)
-22.86%
Return on Equity (ttm)
-170.97%
Revenue (ttm)
113.69M
Net Income Avi to Common (ttm)
-127.98M
Diluted EPS (ttm)
-36.90
Balance Sheet and Cash Flow
Total Cash (mrq)
158.68M
Total Debt/Equity (mrq)
752.67%
Levered Free Cash Flow (ttm)
-69.93M